Resources Contact Us Home
43 Kd protein vaccine and method for the production thereof

Image Number 2 for United States Patent #5543304.

A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in a vaccine provides immunity against multiple serotypes of APP.

  Recently Added Patents
Inductance element
Communications in an asynchronous cellular wireless network
Sacrificial spacer approach for differential source/drain implantation spacers in transistors comprising a high-k metal gate electrode structure
Aqueous composition with agents to inhibit water evaporation
Systems and methods for synchronizing and controlling multiple image sensors
Providing policy-based operating system services in an operating system on a computing system
  Randomly Featured Patents
Protective circuit for transistorized inverter-rectifier apparatus
Salinity measuring system
Skateboard truck
Folding, straight-line, workpiece guide for a band saw
Footbag pads externally mounted to footwear, constructed for catching, juggling, and tossing a footbag
Wellhead housing bootstrap device
Pyrotechnical dowel
Device for feeding flat material
Walkways for platforms on offshore marine structures
System and method for updating a basic input/output system